About Us
Developing novel treatments to address androgenic alopecia.
Amplifica is a biopharmaceutical company focused on developing novel treatments to address androgenic alopecia (hair loss), a condition estimated to affect over 50 million men and over 30 million women in the United States alone. The Company has identified and isolated unique signaling molecules that stimulate hair follicles to regrow hair.
Amplifica will be initiating clinical trials to evaluate the safety and efficacy of its core technology as well as obtaining all applicable regulatory approvals.
Company Overview
Focused on addressing significant unmet need for safe and efficacious products that can grow new hair.
Differentiated product pipeline is focused on addressing hair loss for men and women with robust proof of concept data targeting multiple mechanisms of action.
Company Overview
Early proof of concept human clinical data showcases strong safety and efficacy with Amplifica’s lead compound AMP-303.
Company Overview
Strong pipeline focused on addressing hair loss for men and women with robust proof of concept data
- Pipeline compounds target multiple mechanisms of action
- Strong, granted IP position
Company Overview
Founded and managed by a strong team of executives with a proven track record in aesthetics medicine.
Leadership
Our Proven
Leadership Team
Frank Fazio
President & CEO
Wajdie Ahmad, MBA
Co-founder, COO
Maksim Plikus, PhD
Co-founder, CSO
William Rassman, MD
Co-founder, CMO
Board of Directors
Our Experienced Board of Directors
Executive Chairman,
Co-Founder and
Chief Operating Officer
Director, President and Chief Executive Officer
Co-Founder and Director
Director
Director
Director